Reason Round Table: A weekly discussion group for thoughtful, curious people

Rethinking Medical Trials: At present, medical trial participation is limited based on a number of factors (health status, availability of existing treatment options, etc). Should participation be opened up to all those who would like to explore other options, regardless of health status, if they give consent? What are the benefits to approaching trials in this manner? What are the potential downsides?

https://www.pharmacytimes.com/view/review-of-3-alternative-pathways-to-access-non-fda-approved-drugs

https://www.nature.com/articles/d41586-021-01099-4

https://www.ncbi.nlm.nih.gov/books/NBK66194/#:~:text=
https://learn.hms.harvard.edu/insights/all-insights/exploring-ethics-clinical-research

https://schaeffer.usc.edu/research/lack-of-diversity-in-clinical-trials-costs-billions-of-dollars-incentives-can-spur-innovation/